Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 94 articles:
HTML format
Text format



Single Articles


    April 2019
  1. BUTT AA, Yan P, Aslam S, Shaikh OS, et al
    Hepatitis C Virus Treatment with Directly Acting Agents Reduces the Risk of Incident Diabetes - Results from ERCHIVES.
    Clin Infect Dis. 2019 Apr 12. pii: 5448895. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. YOUNOSSI ZM, Stepanova M, Jacobson I, Muir AJ, et al
    Not Achieving Sustained Viral Eradication of Hepatitis C Virus After Treatment Leads to Worsening of Patient-Reported Outcomes.
    Clin Infect Dis. 2019 Apr 5. pii: 5428146. doi: 10.1093.
    PubMed     Text format     Abstract available


  3. BERTISCH B, Brezzi M, Negro F, Mullhaupt B, et al
    Very low hepatitis C viral loads in treatment-naive persons: do they compromise hepatitis C virus antigen testing?
    Clin Infect Dis. 2019 Apr 3. pii: 5426964. doi: 10.1093.
    PubMed     Text format     Abstract available


  4. MATHUR P, Kottilil S
    Hepatitis C core antigen testing: Still an effective diagnostic method for global elimination of hepatitis C.
    Clin Infect Dis. 2019 Apr 3. pii: 5426965. doi: 10.1093.
    PubMed     Text format    


  5. SORIANO V, Gomez-Gallego F, Corral O
    Hepatitis delta estimates in the United States revisited.
    Clin Infect Dis. 2019 Apr 3. pii: 5426967. doi: 10.1093.
    PubMed     Text format    


    March 2019
  6. SALVADORI N, Fan B, Teeyasoontranon W, Ngo-Giang-Huong N, et al
    Maternal and Infant Bone Mineral Density 1 Year After Delivery in a Randomized, Controlled Trial of Maternal Tenofovir Disoproxil Fumarate to Prevent Mother-to-child Transmission of Hepatitis B Virus.
    Clin Infect Dis. 2019 Mar 29. pii: 5422240. doi: 10.1093.
    PubMed     Text format     Abstract available


  7. GANE E, Poordad F, Zadeikis N, Valdes J, et al
    Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver Disease.
    Clin Infect Dis. 2019 Mar 28. pii: 5421746. doi: 10.1093.
    PubMed     Text format     Abstract available


  8. KISER JJ
    Safety of Hepatitis C Viral Protease Inhibitors in Compensated Cirrhotics: Lingering Concerns Put to Rest?
    Clin Infect Dis. 2019 Mar 28. pii: 5421743. doi: 10.1093.
    PubMed     Text format    


  9. LUI GCY, Wong NS, Wong RYK, Tse YK, et al
    Antiviral therapy for hepatitis B prevents liver injury in patients with tuberculosis and hepatitis B co-infection.
    Clin Infect Dis. 2019 Mar 22. pii: 5421304. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2019
  10. BOETTIGER DC, Salazar-Vizcaya L, Dore GJ, Gray RT, et al
    Can Australia reach the World Health Organization Hepatitis C elimination goal by 2025 among HIV-positive gay and bisexual men?
    Clin Infect Dis. 2019 Feb 28. pii: 5366676. doi: 10.1093.
    PubMed     Text format     Abstract available


  11. GEDDES L, Iversen J, Wand H, Esmaeili A, et al
    Sex discrepancies in the protective effect of opioid agonist therapy on incident hepatitis C infection.
    Clin Infect Dis. 2019 Feb 28. pii: 5366653. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. CHEN SH, Lai HC, Chiang IP, Su WP, et al
    Performance of Acoustic Radiation Force Impulse Elastography for Staging Liver Fibrosis in Patients with Chronic Hepatitis C after Viral Eradication.
    Clin Infect Dis. 2019 Feb 28. pii: 5366592. doi: 10.1093.
    PubMed     Text format     Abstract available


  13. RAMIERE C, Charre C, Miailhes P, Bailly F, et al
    Patterns of HCV transmission in HIV-infected and HIV-negative men having sex with men.
    Clin Infect Dis. 2019 Feb 27. pii: 5365873. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. BROUWER WP, Chan HL, Lampertico P, Hou J, et al
    Genome Wide Association Study Identifies Genetic Variants Associated With Early And Sustained Response To (Peg)Interferon In Chronic Hepatitis B Patients: The GIANT-B Study.
    Clin Infect Dis. 2019 Feb 2. pii: 5305981. doi: 10.1093.
    PubMed     Text format     Abstract available


  15. CHAUDHURY CS, Mee T, Chairez C, McLaughlin M, et al
    Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance.
    Clin Infect Dis. 2019 Feb 2. pii: 5305922. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. BROWN TT
    Hypogonadism in Men With Hepatitis C: What Is a Clinician to Do?
    Clin Infect Dis. 2019 Feb 2. pii: 5305923. doi: 10.1093.
    PubMed     Text format    


    January 2019
  17. CHAILLON A, Rand EB, Reau N, Martin NK, et al
    Cost-Effectiveness of Universal Hepatitis C Virus Screening of Pregnant Women in The United States.
    Clin Infect Dis. 2019 Jan 28. pii: 5303781. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. MCAULEY JB, Close R
    Better Guidance on Treating HCV in Pregnancy: The Time is Now.
    Clin Infect Dis. 2019 Jan 7. pii: 5275237. doi: 10.1093.
    PubMed     Text format    


  19. BRESKIN A, Westreich D, Hurt CB, Cole SR, et al
    The effects of hepatitis C treatment eligibility criteria on all-cause mortality among people with HIV.
    Clin Infect Dis. 2019 Jan 7. pii: 5274661. doi: 10.1093.
    PubMed     Text format     Abstract available


  20. PATEL EU, Thio CL, Boon D, Thomas DL, et al
    Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011-2016.
    Clin Infect Dis. 2019 Jan 3. pii: 5272449. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2018
  21. LOOMBA R, Decaris M, Li KW, Shankaran M, et al
    Discovery of half-life of circulating HBsAg in patients with chronic hepatitis B infection using heavy water labeling.
    Clin Infect Dis. 2018 Dec 24. pii: 5259172. doi: 10.1093/cid/ciy1100.
    PubMed     Text format     Abstract available


    October 2018
  22. TALAL AH, Andrews P, Mcleod A, Chen Y, et al
    Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus (HCV) Management in Opioid Use Disorder Patients on Methadone.
    Clin Infect Dis. 2018 Oct 17. pii: 5133592. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. BRESKIN A, Westreich D, Cole SR, Hudgens MG, et al
    The Effects of Hepatitis C Infection and Treatment on All-cause Mortality Among People Living With Human Immunodeficiency Virus.
    Clin Infect Dis. 2018 Oct 12. pii: 5128783. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2018
  24. TIO SY, Nickless D, McCracken J, Nedumannil R, et al
    A Man With Tonsillitis and Hepatitis.
    Clin Infect Dis. 2018;67:1303-1305.
    PubMed     Text format    


  25. LAI JC, Wong GL, Yip TC, Tse YK, et al
    Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016.
    Clin Infect Dis. 2018;67:1278-1284.
    PubMed     Text format     Abstract available


  26. PATEL EU, Mehta SH, Boon D, Quinn TC, et al
    Limited Coverage of Hepatitis C Virus Testing in the United States, 2013-2017.
    Clin Infect Dis. 2018 Sep 15. pii: 5098442. doi: 10.1093.
    PubMed     Text format     Abstract available



  27. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.
    Clin Infect Dis. 2018 Sep 12. pii: 5095352. doi: 10.1093.
    PubMed     Text format     Abstract available


  28. JHAVERI R, Broder T, Bhattacharya D, Peters MG, et al
    Universal Screening of Pregnant Women for Hepatitis C: The Time Is Now.
    Clin Infect Dis. 2018 Sep 12. pii: 5095353. doi: 10.1093.
    PubMed     Text format     Abstract available


    August 2018
  29. BUTT AA, Yan P, Lo Re V 3rd, Shaikh OS, et al
    Trends in Treatment Uptake and Provider Specialty for HCV Infection in the VA Healthcare System: Results from ERCHIVES.
    Clin Infect Dis. 2018 Aug 22. pii: 5077936. doi: 10.1093.
    PubMed     Text format     Abstract available


  30. SULKOWSKI MS
    The Proof Is in the Patient: Hepatitis C Virus Microelimination in the Swiss Human Immunodeficiency Virus Cohort Study.
    Clin Infect Dis. 2018 Aug 13. pii: 5071944. doi: 10.1093.
    PubMed     Text format    


  31. BRAUN DL, Hampel B, Martin E, Kouyos R, et al
    High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men.
    Clin Infect Dis. 2018 Aug 13. pii: 5071946. doi: 10.1093.
    PubMed     Text format     Abstract available


  32. BRAUN DL, Hampel B, Kouyos R, Nguyen H, et al
    High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men.
    Clin Infect Dis. 2018 Aug 13. pii: 5071945. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2018
  33. BIXLER D, Zhong Y, Ly KN, Moorman AC, et al
    Mortality among Patients with Chronic Hepatitis B (CHB) Infection: the Chronic Hepatitis Cohort Study (CHeCS).
    Clin Infect Dis. 2018 Jul 28. pii: 5061152. doi: 10.1093.
    PubMed     Text format     Abstract available


  34. SMITH D, Huynh C, Moore AJ, Frick A, et al
    Herd Immunity Likely Protected the Men who have Sex with Men in Recent Hepatitis A Outbreak in San Diego CA.
    Clin Infect Dis. 2018 Jul 25. pii: 5059685. doi: 10.1093.
    PubMed     Text format     Abstract available


    June 2018
  35. KILMER GA, Barker LK, Ly KN, Jiles RB, et al
    Hepatitis B vaccination and screening among foreign-born women of reproductive age in the United States: 2013-2015.
    Clin Infect Dis. 2018 Jun 1. pii: 5026244. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2018
  36. HOSRY J, Angelidakis G, Kaseb A, Jiang Y, et al
    Inhibition of Hepatitis C Virus Replication Induced by Chemotherapy: A Prospective Observational Study.
    Clin Infect Dis. 2018 May 15. pii: 4996053. doi: 10.1093.
    PubMed     Text format    


  37. ALROY-PREIS S, Daly ER, Adamski C, Dionne-Odom J, et al
    Large Outbreak of Hepatitis C Virus Associated With Drug Diversion by a Healthcare Technician.
    Clin Infect Dis. 2018 May 14. pii: 4995993. doi: 10.1093.
    PubMed     Text format     Abstract available


  38. MEISSNER EG
    The Gut-Liver Axis in Hepatitis C Virus Infection: A Path Towards Altering the Natural History of Fibrosis Progression?
    Clin Infect Dis. 2018 May 1. pii: 4989914. doi: 10.1093.
    PubMed     Text format    


  39. INOUE T, Nakayama J, Moriya K, Kawaratani H, et al
    Gut Dysbiosis Associated With Hepatitis C Virus Infection.
    Clin Infect Dis. 2018 May 1. pii: 4989908. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2018
  40. HECTOR J, Vinikoor M, Chilengi R, Ehmer J, et al
    No Impact of Hepatitis B Virus Infection on Early Mortality among HIV-infected Patients in Southern Africa.
    Clin Infect Dis. 2018 Apr 18. pii: 4975531. doi: 10.1093.
    PubMed     Text format    


  41. LEE YL, Chen GJ, Chen NY, Liou BH, et al
    Less Severe but Prolonged Course of Acute Hepatitis A in HIV-positive Patients than HIV-negative Patients During an Outbreak: A Multicenter Observational Study.
    Clin Infect Dis. 2018 Apr 17. pii: 4972863. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2018
  42. WALKER A, Boyce A, Geller G, Thio CL, et al
    Direct Acting Antivirals and Hepatitis C: The Ethics of Price and Rationing by Genotype.
    Clin Infect Dis. 2018 Mar 29. pii: 4956154. doi: 10.1093.
    PubMed     Text format    


  43. ROCKSTROH JK, Lacombe K, Viani RM, Orkin C, et al
    Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Co-infected with Hepatitis C Virus and Human Immunodeficiency Virus-1: the EXPEDITION-2 Study.
    Clin Infect Dis. 2018 Mar 16. pii: 4939381. doi: 10.1093.
    PubMed     Text format     Abstract available


  44. BARTLETT SR, Fox P, Cabatingan H, Jaros A, et al
    Demonstration of near-elimination of hepatitis C virus among a prison population: the Lotus Glen Correctional Centre hepatitis C treatment project.
    Clin Infect Dis. 2018 Mar 12. pii: 4930770. doi: 10.1093.
    PubMed     Text format     Abstract available


  45. KLEINSTEIN SE, Shea PR, Stamm LM, Sulkowski M, et al
    Association of CYP2B6 Single-Nucleotide Polymorphisms Altering Efavirenz Metabolism With Hepatitis C Virus (HCV) Treatment Relapse Among Human Immunodeficiency Virus/HCV-Coinfected African Americans Receiving Ledipasvir/Sofosbuvir in the ION-4 Trial.
    Clin Infect Dis. 2018 Mar 7. pii: 4705930. doi: 10.1093/cid/cix1051.
    PubMed     Text format     Abstract available


  46. MOGALIAN E, Stamm LM, Osinusi A, Brainard DM, et al
    Drug-Drug Interactions Studies between HCV Antivirals Sofosbuvir/Velpatasvir and Boosted and Unboosted HIV Antiretroviral Regimens in Healthy Volunteers.
    Clin Infect Dis. 2018 Mar 7. pii: 4924529. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2018
  47. BAROCAS JA, Tasillo A, Eftekhari Yazdi G, Wang J, et al
    Population level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States.
    Clin Infect Dis. 2018 Feb 6. pii: 4840186. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2018
  48. TROPPY S, Soliva S, Onofrey S, DeMaria A Jr., et al
    Geographic Disparities in Access to Syringe Services Programs Among Young Persons with Hepatitis C Virus Infection in Massachusetts.
    Clin Infect Dis. 2018 Jan 31. pii: 4831117. doi: 10.1093.
    PubMed     Text format    


    December 2017
  49. HUA S, Vigano S, Tse S, Zhengyu O, et al
    Pegylated IFN-alpha-induced NK cell activation is associated with HIV-1 DNA decline in ART-treated HIV-1/HCV co-infected patients.
    Clin Infect Dis. 2017 Dec 20. pii: 4767848. doi: 10.1093/cid/cix1111.
    PubMed     Text format     Abstract available


  50. YOUNOSSI ZM, Stepanova M, Asselah T, Foster G, et al
    Hepatitis C in Patients with Minimal or No Hepatic Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes.
    Clin Infect Dis. 2017 Dec 20. pii: 4766885. doi: 10.1093/cid/cix1106.
    PubMed     Text format     Abstract available


  51. RICKLES M, Rebeiro PF, Sizemore L, Juarez P, et al
    Tennessee's In-State Vulnerability Assessment for a 'Rapid Dissemination of HIV or HCV Infection' Event Utilizing Data about the Opioid Epidemic.
    Clin Infect Dis. 2017 Dec 7. pii: 4706246. doi: 10.1093/cid/cix1079.
    PubMed     Text format     Abstract available


  52. KAPADIA SN, Jeng PJ, Schackman BR, Bao Y, et al
    State Medicaid hepatitis C treatment eligibility criteria and use of direct acting antivirals.
    Clin Infect Dis. 2017 Dec 1. pii: 4682615. doi: 10.1093/cid/cix1062.
    PubMed     Text format     Abstract available


    November 2017
  53. BOEREKAMPS A, Newsum AM, Smit C, Arends JE, et al
    High treatment uptake in HIV/HCV-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands.
    Clin Infect Dis. 2017 Nov 23. pii: 4654728. doi: 10.1093/cid/cix1004.
    PubMed     Text format     Abstract available


  54. ROCKSTROH JK
    Is HCV elimination in well-defined patient groups possible?
    Clin Infect Dis. 2017 Nov 23. pii: 4654730. doi: 10.1093/cid/cix1010.
    PubMed     Text format    


  55. BOEREKAMPS A, Van den Berk GE, Fanny LN, Leyten EM, et al
    Declining HCV incidence in Dutch HIV positive men who have sex with men after unrestricted access to HCV therapy.
    Clin Infect Dis. 2017 Nov 23. pii: 4654729. doi: 10.1093/cid/cix1007.
    PubMed     Text format     Abstract available


  56. BEDIMO RJ, Adams-Huet B, Poindexter J, Brown G, et al
    The Differential Effects of HIV and HCV on Bone Micro-Architecture and Fracture risk.
    Clin Infect Dis. 2017 Nov 14. doi: 10.1093/cid/cix1011.
    PubMed     Text format     Abstract available


    October 2017
  57. DE LEDINGHEN V, Laforest C, Hezode C, Pol S, et al
    Retreatment with sofosbuvir plus grazoprevir/elbasvir plus ribavirin of patients with hepatitis C virus genotype 1 or 4 who previously failed a NS5A or NS3-containing regimen. ANRS HC34 REVENGE.
    Clin Infect Dis. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available


  58. YAYA I, Costa M, Marcellin F, Miailhes P, et al
    Gender, alcohol use and fibrosis in HIV-HCV co-infected individuals.
    Clin Infect Dis. 2017 Oct 23. doi: 10.1093.
    PubMed     Text format    


  59. PARR JB, Lodge EK, Holzmayer V, Pepin J, et al
    An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots.
    Clin Infect Dis. 2017 Oct 18. doi: 10.1093.
    PubMed     Text format     Abstract available


    September 2017
  60. BUTT AA, Yan P, Simon TG, Abou-Samra AB, et al
    Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus-Infected Persons: Results From ERCHIVES.
    Clin Infect Dis. 2017;65:1006-1011.
    PubMed     Text format     Abstract available


  61. HASHEM M, Jhaveri R, Saleh DA, Sharaf SA, et al
    Spontaneous Viral Load Decline and Subsequent Clearance of Chronic Hepatitis C Virus in Postpartum Women Correlates With Favorable Interleukin-28B Gene Allele.
    Clin Infect Dis. 2017;65:999-1005.
    PubMed     Text format     Abstract available


  62. ASSOUMOU SA, Tasillo A, Leff JA, Schackman BR, et al
    The cost-effectiveness of one-time hepatitis C screening strategies among adolescents and young adults in primary care settings.
    Clin Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  63. CHHATWAL J
    Hepatitis C screening: From modeling to public health policy.
    Clin Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format    


  64. LIU CH, Chen YS, Wang SS, Liu CJ, et al
    Sofosbuvir-based interferon-free direct acting antiviral regimens for heart transplant recipients with chronic hepatitis C virus infection.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format     Abstract available


  65. WEINBERG EM, Reddy KR
    Let's Make a Deal: Shortening the solid organ transplant waiting time in exchange for transmitting and treating Hepatitis C infection in the era of safe and effective DAAs.
    Clin Infect Dis. 2017 Sep 4. doi: 10.1093.
    PubMed     Text format    


    August 2017
  66. ESMAEILI A, Mirzazadeh A, Morris MD, Hajarizadeh B, et al
    The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative.
    Clin Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  67. ABRAHAM GM, Spooner LM
    Citius Altius Fortius: The New Paradigm In The Treatment Of Chronic Hepatitis C Disease.
    Clin Infect Dis. 2017 Aug 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  68. KOUAME GM, Boyd A, Moh R, Badje A, et al
    Higher mortality despite early ART in HIV and hepatitis B virus coinfected patients with high HBV replication.
    Clin Infect Dis. 2017 Aug 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  69. WANG H, Wan Z, Xu R, Guan Y, et al
    A Novel Human Pegivirus HPgV-2 (HHpgV-1) is Tightly Associated with HCV Infection and HCV/HIV-1 Co-Infection.
    Clin Infect Dis. 2017 Aug 19. doi: 10.1093.
    PubMed     Text format     Abstract available


  70. KELLY EM, Dodge JL, Bacchetti P, Sarkar M, et al
    Moderate Alcohol use is not Associated with Fibrosis Progression in HIV/HCV Co-Infected Women: A Prospective Cohort Study.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


  71. LO RE V 3RD
    Is Moderate Alcohol Consumption Safe for HIV/Hepatitis C Virus-Coinfected Women?
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format    


  72. BYRNE DD, Tate JP, Forde KA, Lim JK, et al
    Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.
    Clin Infect Dis. 2017 Aug 16. doi: 10.1093.
    PubMed     Text format     Abstract available


    July 2017
  73. SARKAR M, Dodge JL, Greenblatt RM, Kuniholm MH, et al
    Reproductive Aging and Hepatic Fibrosis Progression in HIV/Hepatitis C Virus Co-Infected Women.
    Clin Infect Dis. 2017 Jul 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  74. POWDERLY WG, Naggie S, Kim AY, Vargas HE, et al
    IDSA/AASLD response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C.
    Clin Infect Dis. 2017 Jul 17. doi: 10.1093.
    PubMed     Text format    


    June 2017
  75. CHI H, Wong D, Peng J, Cao J, et al
    Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation.
    Clin Infect Dis. 2017 Jun 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  76. KIM AY
    The National Academy Report on the Elimination of Viral Hepatitis: An Infectious Disease Physician's Perspective.
    Clin Infect Dis. 2017 May 27. doi: 10.1093.
    PubMed     Text format    


  77. FELD JJ, Ramji A, Shafran SD, Willems B, et al
    Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study.
    Clin Infect Dis. 2017 May 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  78. ZUCMAN D, Farfour E, Mazaux L, Hillaire S, et al
    How to face the outbreak of viral hepatitis A in men-who-have-sex-with-men in France without vaccines?
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format    


  79. BOSCHI C, Colson P, Tissot-Dupont H, Bernit E, et al
    Hepatitis C virus relapse 78 weeks after completion of successful direct acting therapy.
    Clin Infect Dis. 2017 May 16. doi: 10.1093.
    PubMed     Text format    


  80. MOON J, Hyland RH, Zhang F, Brainard DM, et al
    Efficacy and safety of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C in persons with sickle cell disease.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  81. ROSENBERG ES, Hall EW, Sullivan PS, Sanchez TH, et al
    Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010.
    Clin Infect Dis. 2017 Apr 26. doi: 10.1093.
    PubMed     Text format     Abstract available


  82. OZARAS R, Balkan II, Yemisen M, Mete B, et al
    Reactivation of Hepatitis B Virus Following Treatment of Hepatitis C Virus Infection in Coinfected Patients.
    Clin Infect Dis. 2017 Apr 24. doi: 10.1093.
    PubMed     Text format    


  83. BUTT AA, Yan P, Chew KW, Currier J, et al
    Risk of Acute Myocardial Infarction Among HCV+ and HCV- Men at Various Lipid Levels: Results from ERCHIVES.
    Clin Infect Dis. 2017 Apr 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  84. TIEN PC
    HCV-associated Alterations in Lipid and Lipoprotein levels: Helpful or Harmful to the Heart?
    Clin Infect Dis. 2017 Apr 24. doi: 10.1093.
    PubMed     Text format    


  85. CANARY L, Hariri S, Campbell C, Young R, et al
    Geographic disparities in access to syringe services programs among young people with hepatitis C virus infection in the U.S.
    Clin Infect Dis. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available


  86. MORRIS MD, Shiboski S, Bruneau J, Hahn JA, et al
    Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.
    Clin Infect Dis. 2017;64:860-869.
    PubMed     Text format     Abstract available


  87. NOSKA AJ, Belperio PS, Loomis TP, O'Toole TP, et al
    Prevalence of HIV, HCV and HBV among Homeless and Non-homeless United States Veterans.
    Clin Infect Dis. 2017 Apr 1. doi: 10.1093.
    PubMed     Text format     Abstract available


    March 2017
  88. WYLES D, Brau N, Kottilil S, Daar ES, et al
    Sofosbuvir and Velpatasvir for the Treatment of HCV in Patients Coinfected with HIV-1: an Open-Label, Phase 3 Study.
    Clin Infect Dis. 2017 Mar 29. doi: 10.1093.
    PubMed     Text format     Abstract available


  89. BUTT AA, Ren Y, Lo Re V 3rd, Taddei T, et al
    Comparing Child-Pugh, MELD and FIB-4 to Predict Clinical Outcomes in HCV-Infected Persons: Results from ERCHIVES.
    Clin Infect Dis. 2017 Mar 22. doi: 10.1093.
    PubMed     Text format     Abstract available


  90. CEPEDA JA, Thomas DL, Astemborski J, Sulkowski MS, et al
    Increased mortality among persons with chronic hepatitis C with moderate or severe liver disease: a cohort study.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    PubMed     Text format     Abstract available


  91. HEZODE C, Fourati S, Chevaliez S, Scoazec G, et al
    Sofosbuvir-Daclatasvir-Simeprevir plus Ribavirin in Direct-Acting Antiviral-Experienced Hepatitis C Patients.
    Clin Infect Dis. 2017 Mar 10. doi: 10.1093.
    PubMed     Text format     Abstract available


    February 2017
  92. NAGGIE S, Marks KM, Hughes M, Fierer DS, et al
    Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
    Clin Infect Dis. 2017 Feb 27. doi: 10.1093.
    PubMed     Text format     Abstract available


  93. VINIKOOR MJ, Sinkala E, Chilengi R, Mulenga L, et al
    Impact of antiretroviral therapy on liver fibrosis among HIV-infected adults with and without HBV coinfection in Zambia.
    Clin Infect Dis. 2017 Feb 4. doi: 10.1093.
    PubMed     Text format    


    August 2016
  94. WITTKOP L
    Endstage liver disease in HIV infection: an avoidable burden?
    Clin Infect Dis. 2016.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: